Navigation Links
Pacira Pharmaceuticals, Inc. Reports Third Quarter 2011 Financial Results
Date:10/31/2011

f the launch of EXPAREL.
  • As of September 30, 2011, Pacira had unrestricted cash, cash equivalents and short term investments of $37.1 million compared with $26.1 million on December 31, 2010.
  • Cash used in operating activities and for the purchase of fixed assets used in investing activities ("cash burn") was approximately $27 million for the nine months ended September 30, 2011.  

  • Full Year 2011 Financial Guidance

  • Pacira is reiterating its revenue expectations for 2011 and currently expects to achieve revenue in the range of $14 to $16 million for the full-year ending December 31, 2011.  This revenue expectation excludes the impact of potential sales of EXPAREL.
  • Pacira is also reiterating that its expectation for cash burn for the fourth quarter of 2011 is approximately $15 million. This cash burn expectation includes a $2 million development milestone due from Novo Nordisk A/S under the agreement announced in January 2011.  As a result, Pacira expects to exit 2011 with approximately $22 million in unrestricted cash, cash equivalents and short-term investments.

  • Upcoming ActivitiesPacira expects to present at the following investor conferences:

  • 2011 Brean Murray, Carret & Co. Life Sciences Summit, November 14, in New York
  • 23rd Annual Piper Jaffray Healthcare Conference, November 29-30, in New York

  • Pacira expects to have a presence at the following medical meetings:

  • American College of Toxicology (ACT), November 6-9, in New York
  • American Society of Health-System Pharmacists (ASHP), December 4-8, in New Orleans
  • Postgraduate Assembly in Anesthesiology (PGA), New York State Society of Anesthesiologists (NYSSA), December 9-13, in New York
  • New York School of Regional Anesthesia (NYSORA), December 17-18, in New York

  • Today's Conference Call and Webcast ReminderThe Pacira management team will host a conference call di
    '/>"/>

    SOURCE Pacira Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
    2. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
    3. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
    4. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
    5. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
    6. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
    7. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
    8. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
    9. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
    10. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
    11. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/10/2014)... , July 10, 2014 CVS Caremark Corporation ... of directors has approved a quarterly dividend of $0.275 (27.5 ... is payable on August 1, 2014, to holders of record ... CVS Caremark is dedicated to helping people on ... company in the United States . Through ...
    (Date:1/15/2014)...  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the ... Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... in order to treat dental impairments, for tooth restoration ...
    (Date:1/15/2014)... 2014 Massachusetts General Hospital (MGH), the Broad ... announced today that they have launched a strategic ... targets and develop novel therapies for inflammatory bowel ... worldwide. The MGH-Broad-Amgen collaboration brings together scientists with ...
    Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
    ... , , JERUSALEM , ... Dr. Amatruda is the Former Senior Vice President and Franchise Head of,the ... Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB; http://www.oramed.com ), a,developer of oral ... Oramed,s Scientific Advisory Board, enhancing Oramed,s,talented and experienced scientific team. , ...
    ... , , MOUNTAIN VIEW, Calif. ... ) announced today that it will host an investor/analyst meeting on ... ET , in New York City . , The meeting will ... CEO, Alexza Pharmaceuticals James Cassella , PhD - ...
    Cached Medicine Technology:Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D. 2Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D. 3Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 2Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 3Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 4
    (Date:7/11/2014)... Riverside Health System became the first provider of ... 2012 and now, in partnership with Williamsburg Landing, will offer ... and Newport News region. , Also known as life care ... older adults who wish to remain in their homes but ... care services as well as control over the cost of ...
    (Date:7/11/2014)... Pigments are insoluble colorants, which usually consist of ... coating, opacity, and coloring. These are water and oil ... substances such as paper, paints, plastics, and concrete. Binders ... impart color to the substance. Some examples of pigments ... , The coloring action of pigments is due to ...
    (Date:7/11/2014)... Riviera Maya, Mexico (PRWEB) July 11, 2014 ... Mexico with the Mayan Heritage Experience Package at the ... Highlights of the package include a guided on-site ecological ... fauna, as well as The Coba Mayan Encounter Tour ... also climb Nohoch Muul, the tallest pyramid in the ...
    (Date:7/11/2014)... Recently, Fadhits.com, the distinguished wedding dress manufacturer ... prom dresses . To bring more benefits to worldwide clients ... a special offer for these brand new items. Clients can ... company’s sales manager says gladly, “We are happy to announce ... to acknowledge all new and old customers and strengthen our ...
    (Date:7/11/2014)... that people who have grown up on a farm ... urban counterparts to develop the most common inflammatory bowel ... have recently been published in the European Journal ... we can now see that not only allergic diseases, ... on the environment we are exposed to early in ...
    Breaking Medicine News(10 mins):Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 4Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 2Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 3Health News:Explore the Aura and Mystery of the Yucatan’s Mayan Culture with New Hotel Package at AAA Five Diamond Grand Velas Riviera Maya 2Health News:Explore the Aura and Mystery of the Yucatan’s Mayan Culture with New Hotel Package at AAA Five Diamond Grand Velas Riviera Maya 3Health News:Promotion for Kids Prom Dresses Now Provided at Fadhits.com 2Health News:Growing up on a livestock farm halves the risk of inflammatory bowel diseases 2
    ... use of complementary and alternative medicine (CAM) in over 2000 ... from acupuncture to yoga - has increased in popularity since ... medicine has always been popular, although the type of therapies ... ,The greatest increase in popularity was in the transition ...
    ... found a cheap and non toxic method of treating Hepatitis, ... virus infects the liver, and in severe cases can lead ... through contact with the blood or body fluids of an ... HBV after a very bright and aware patient observed that ...
    ... gives powerful relief for chronic pain, and should be ... told a conference in Glasgow.,Dr William Notcutt of the ... cannabis extract used in his study - applied as ... in easing chronic pain. He announced the findings at ...
    ... Both drugs and surgery may be effective in treating Meniere's ... the hearing apparatus. A build up of pressure causes vertigo ... leads to hearing loss in the affected ear, and the ... ,This disease has a wide range of treatments available.Many ...
    ... form of arterial disease appear to have low levels of ... smoking habits. ,Peripheral artery disease (PAD) is a form of ... arteries and obstructs blood flow. In PAD, blood flow in ... and pain. PAD is also associated with an increased risk ...
    ... the number of miles you fly affects your risk of ... increase the risk of blood clotting in the veins of ... breaks off, it may travel to the lungs, forming a ... ,Researchers in France and the US have monitored all ...
    Cached Medicine News:
    Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
    Double-ended. Designated most popular model or size....
    Designated most popular model or size. Double-ended. 2 mm wide....
    Desmarres Retractor Size 4...
    Medicine Products: